title: Spironolactone-induced bilateral gynecomastia in a man detected by SPECT myocardial perfusion imaging.
authors.affiliation: Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Lyons Harrison Research Building 306, 1720 2nd AVE S, Birmingham, AL, 35294, USA.
authors.forename: Ayman A
authors.initials: AA
authors.lastname: Farag
authors.affiliation: Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Lyons Harrison Research Building 306, 1720 2nd AVE S, Birmingham, AL, 35294, USA.
authors.forename: Efstathia
authors.initials: E
authors.lastname: Andrikopoulou
authors.affiliation: Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Lyons Harrison Research Building 306, 1720 2nd AVE S, Birmingham, AL, 35294, USA. fadihage@uab.edu.|Section of Cardiology, Birmingham Veterans Affairs Medical Center, Birmingham, AL, USA. fadihage@uab.edu.
authors.forename: Fadi G
authors.initials: FG
authors.lastname: Hage
mesh_terms: D006177:Gynecomastia / Q000139:chemically induced* / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D008875:Middle Aged; D055414:Myocardial Perfusion Imaging / Q000379:methods*; D013148:Spironolactone / Q000009:adverse effects*; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*
chemical_list: D013148:Spironolactone